MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene.
|
20929961 |
2011 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency.
|
21057504 |
2010 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I.
|
20816094 |
2010 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency.
|
21057504 |
2010 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.
|
17564966 |
2007 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.
|
17564966 |
2007 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.
|
17564966 |
2007 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Acidosis, Lactic
|
0.140 |
GeneticVariation
|
phenotype |
BEFREE |
Disease causing biallelic variants in ACAD9 have been reported in individuals presenting with lactic acidosis and cardiomyopathy.
|
30025539 |
2018 |
Acidosis, Lactic
|
0.140 |
GeneticVariation
|
phenotype |
BEFREE |
Lifetime exercise intolerance with lactic acidosis as key manifestation of novel compound heterozygous ACAD9 mutations causing complex I deficiency.
|
28279569 |
2017 |
Acidosis, Lactic
|
0.140 |
GeneticVariation
|
phenotype |
BEFREE |
We describe the first autopsy in fatal neonatal lethal lactic acidosis due to mutations in ACAD9 that reduced complex I activity.
|
26826406 |
2016 |
Acidosis, Lactic
|
0.140 |
GeneticVariation
|
phenotype |
BEFREE |
One infant with severe lactic acidosis was found to carry two heterozygous variants in ACAD9, which was associated with isolated complex I deficiency and diffuse hypergranular hepatocytes.
|
27483465 |
2016 |
Acidosis, Lactic
|
0.140 |
Biomarker
|
phenotype |
HPO |
|
|
|
Muscle Weakness
|
0.110 |
Biomarker
|
phenotype |
BEFREE |
Mitochondrial acyl-CoA dehydrogenase 9 (ACAD9) deficiency is one of the common causes of respiratory chain complex I deficiency, which is characterized by cardiomyopathy, lactic acidemia, and muscle weakness.
|
31473688 |
2019 |
Hypertrophic Cardiomyopathy
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Here we report a novel ACAD9 mutation in a young girl presenting with severe hypertrophic cardiomyopathy, isolated CI deficiency and interestingly multiple respiratory chain complexes assembly defects.
|
28529009 |
2017 |
Hypertrophic Cardiomyopathy
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle Weakness
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebral Edema
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cardiomyopathy, Dilated
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Failure to Thrive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Fatty Liver
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypoglycemia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cerebrovascular accident
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Thrombocytopenia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|